Yusuf Olğar

A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats

Ayşegül Durak, Yusuf Olğar, Sinan Değirmenci et al. · Cardiovascular Diabetology · 2018 · 176 citations · Full text

Medicine, Cardiology, Pharmacology +17

Aging related functional and structural changes in the heart and aorta: MitoTEMPO improves aged-cardiovascular performance

Yusuf Olğar, Sinan Değirmenci, Ayşegül Durak et al. · Experimental Gerontology · 2018 · 68 citations

Education, Cardiology, Physiology +14

Zn2+-transporters ZIP7 and ZnT7 play important role in progression of cardiac dysfunction via affecting sarco(endo)plasmic reticulum-mitochondria coupling in hyperglycemic cardiomyocytes

Erkan Tuncay, Ceylan Verda Bitirim, Yusuf Olğar et al. · Mitochondrion · 2018 · 54 citations

Life Sciences, Cardiology, Physiology +15

MitoTEMPO provides an antiarrhythmic effect in aged-rats through attenuation of mitochondrial reactive oxygen species

Yusuf Olğar, Deniz Billur, Erkan Tuncay et al. · Experimental Gerontology · 2020 · 45 citations

Life Sciences, Cardiology, Pharmacology +14

Ageing‐associated increase in SGLT2 disrupts mitochondrial/sarcoplasmic reticulum Ca²⁺ homeostasis and promotes cardiac dysfunction

Yusuf Olğar, Erkan Tuncay, Sinan Değirmenci et al. · Journal of Cellular and Molecular Medicine · 2020 · 45 citations · Full text

Life Sciences, Cardiology, Physiology +17